Cargando…
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models
In patients with multiple sclerosis (MS), pain is a frequent and disabling symptom. The prevalence is in the range 29–86 % depending upon the assessment protocols utilised and the definition of pain applied. Neuropathic pain that develops secondary to demyelination, neuroinflammation and axonal dama...
Autores principales: | Khan, Nemat, Smith, Maree T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Basel
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933737/ https://www.ncbi.nlm.nih.gov/pubmed/24234347 http://dx.doi.org/10.1007/s10787-013-0195-3 |
Ejemplares similares
-
Neurotrophins and Neuropathic Pain: Role in Pathobiology
por: Khan, Nemat, et al.
Publicado: (2015) -
Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord
por: Khan, Nemat, et al.
Publicado: (2015) -
Neuropathic cancer pain: prevalence, pathophysiology, and management
por: Yoon, So Young, et al.
Publicado: (2018) -
Nox2-dependent Neuroinflammation in An EAE Model of Multiple Sclerosis
por: Ravelli, Katherine G., et al.
Publicado: (2019) -
Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis
por: Hoffman, Kristina, et al.
Publicado: (2023)